Effect of elobixibat on bile acid metabolism in patients with primary biliary cholangitis or fatty liver
Not Applicable
Recruiting
- Conditions
- primary biliary cholangitis or fatty liver
- Registration Number
- JPRN-UMIN000039146
- Lead Sponsor
- Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients who are suspected to have ileus. 2. patients with severe CKD. 3, patients with severe liver dysfunction (C-P: B or C). 4. Patients with uncontrolled malignancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method serum ALP levels in 12 months in PBC patients serum ALT levels in 12 months in FL patients
- Secondary Outcome Measures
Name Time Method